440 related articles for article (PubMed ID: 7514319)
21. Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.
Hogervorst E; Jurriaans S; de Wolf F; van Wijk A; Wiersma A; Valk M; Roos M; van Gemen B; Coutinho R; Miedema F
J Infect Dis; 1995 Apr; 171(4):811-21. PubMed ID: 7706807
[TBL] [Abstract][Full Text] [Related]
22. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
Ugen KE; Goedert JJ; Boyer J; Refaeli Y; Frank I; Williams WV; Willoughby A; Landesman S; Mendez H; Rubinstein A
J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
[TBL] [Abstract][Full Text] [Related]
23. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.
Zwart G; Back NK; Ramautarsing C; Valk M; van der Hoek L; Goudsmit J
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):245-51. PubMed ID: 8018385
[TBL] [Abstract][Full Text] [Related]
24. Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope.
Davis D; Stephens DM; Carne CA; Lachmann PJ
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2609-17. PubMed ID: 7506300
[TBL] [Abstract][Full Text] [Related]
25. Cross-reactivity between autoimmune anti-U1 snRNP antibodies and neutralizing epitopes of HIV-1 gp120/41.
Douvas A; Takehana Y
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):253-62. PubMed ID: 7517148
[TBL] [Abstract][Full Text] [Related]
26. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
27. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
[TBL] [Abstract][Full Text] [Related]
28. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1).
Neurath AR; Strick N
Mol Immunol; 1990 Jun; 27(6):539-49. PubMed ID: 1696353
[TBL] [Abstract][Full Text] [Related]
29. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
[TBL] [Abstract][Full Text] [Related]
30. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
31. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
[TBL] [Abstract][Full Text] [Related]
32. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology.
Stoiber H; Thielens NM; Ebenbichler C; Arlaud GJ; Dierich MP
Eur J Immunol; 1994 Feb; 24(2):294-300. PubMed ID: 7507842
[TBL] [Abstract][Full Text] [Related]
33. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
34. Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence.
Andrabi R; Choudhary AK; Bala M; Kalra R; Prakash SS; Pandey RM; Luthra K
Arch Virol; 2011 Oct; 156(10):1787-94. PubMed ID: 21735212
[TBL] [Abstract][Full Text] [Related]
35. Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.
Zhang X; Han X; Dai D; Bao M; Zhang Z; Zhang M; Bice T; Zhao M; Cao Y; Shang H
Braz J Infect Dis; 2012; 16(6):510-6. PubMed ID: 23141970
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
37. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
[TBL] [Abstract][Full Text] [Related]
38. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.
Neurath AR; Strick N; Taylor P; Rubinstein P; Stevens CE
AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315
[TBL] [Abstract][Full Text] [Related]
39. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.
Binley JM; Klasse PJ; Cao Y; Jones I; Markowitz M; Ho DD; Moore JP
J Virol; 1997 Apr; 71(4):2799-809. PubMed ID: 9060635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
